Literature DB >> 26428090

Pulmonary emphysema and tumor microenvironment in primary lung cancer.

Junichi Murakami1, Kazuhiro Ueda2, Fumiho Sano1, Masataro Hayashi1, Arata Nishimoto1, Kimikazu Hamano1.   

Abstract

BACKGROUND: To clarify the relationship between the presence of pulmonary emphysema and tumor microenvironment and their significance for the clinicopathologic aggressiveness of non-small cell lung cancer.
METHODS: The subjects included 48 patients with completely resected and pathologically confirmed stage I non-small cell lung cancer. Quantitative computed tomography was used to diagnose pulmonary emphysema, and immunohistochemical staining was performed to evaluate the matrix metalloproteinase (MMP) expression status in the intratumoral stromal cells as well as the microvessel density (MVD).
RESULTS: Positive MMP-9 staining in the intratumoral stromal cells was confirmed in 17 (35%) of the 48 tumors. These 17 tumors were associated with a high MVD, frequent lymphovascular invasion, a high proliferative activity, and high postoperative recurrence rate (all, P < 0.05). The majority of the tumors (13 of 17) arose in patients with pulmonary emphysema (P = 0.02). Lung cancers arising from pulmonary emphysema were also associated with a high MVD, proliferative activity, and postoperative recurrence rate (all, P < 0.05).
CONCLUSIONS: The MMP-9 expression in intratumoral stromal cells is associated with the clinicopathologic aggressiveness of lung cancer and is predominantly identified in tumors arising in emphysematous lungs. Further studies regarding the biological links between the intratumoral and extratumoral microenvironment will help to explain why lung cancers originating in emphysematous lung tissues are associated with a poor prognosis.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Extracellular matrix; Lung cancer; Matrix metalloproteinases; Microenvironment; Pulmonary emphysema

Mesh:

Substances:

Year:  2015        PMID: 26428090     DOI: 10.1016/j.jss.2015.09.004

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  10 in total

Review 1.  Chronic Obstructive Pulmonary Disease and Lung Cancer: Underlying Pathophysiology and New Therapeutic Modalities.

Authors:  Mathew Suji Eapen; Philip M Hansbro; Anna-Karin Larsson-Callerfelt; Mohit K Jolly; Stephen Myers; Pawan Sharma; Bernadette Jones; Md Atiqur Rahman; James Markos; Collin Chia; Josie Larby; Greg Haug; Ashutosh Hardikar; Heinrich C Weber; George Mabeza; Vinicius Cavalheri; Yet H Khor; Christine F McDonald; Sukhwinder Singh Sohal
Journal:  Drugs       Date:  2018-11       Impact factor: 9.546

2.  Regional Emphysema Score Predicting Overall Survival, Quality of Life, and Pulmonary Function Recovery in Early-Stage Lung Cancer Patients.

Authors:  Jie Dai; Ming Liu; Stephen J Swensen; Shawn M Stoddard; Jason A Wampfler; Andrew H Limper; Gening Jiang; Ping Yang
Journal:  J Thorac Oncol       Date:  2017-01-23       Impact factor: 15.609

3.  Prognostic significance of CT-emphysema score in patients with advanced squamous cell lung cancer.

Authors:  Young Saing Kim; Eun Young Kim; Hee Kyung Ahn; Eun Kyung Cho; Yu Mi Jeong; Jeong Ho Kim
Journal:  J Thorac Dis       Date:  2016-08       Impact factor: 2.895

4.  Preoperative risk assessment with computed tomography in patients undergoing lung cancer surgery.

Authors:  Kazuhiro Ueda; Junichi Murakami; Toshiki Tanaka; Masataro Hayashi; Kazunori Okabe; Kimikazu Hamano
Journal:  J Thorac Dis       Date:  2018-07       Impact factor: 2.895

5.  Quantitative Emphysema on Low-Dose CT Imaging of the Chest and Risk of Lung Cancer and Airflow Obstruction: An Analysis of the National Lung Screening Trial.

Authors:  Wassim W Labaki; Meng Xia; Susan Murray; Charles R Hatt; Abdullah Al-Abcha; Michael C Ferrera; Catherine A Meldrum; Lauren A Keith; Craig J Galbán; Douglas A Arenberg; Jeffrey L Curtis; Fernando J Martinez; Ella A Kazerooni; MeiLan K Han
Journal:  Chest       Date:  2020-12-14       Impact factor: 9.410

Review 6.  Lung cancer and chronic obstructive pulmonary disease: From a clinical perspective.

Authors:  Jie Dai; Ping Yang; Angela Cox; Gening Jiang
Journal:  Oncotarget       Date:  2017-03-14

7.  Impact of COPD on prognosis of lung cancer: from a perspective on disease heterogeneity.

Authors:  Wei Wang; Shuang Dou; Wenyan Dong; Mengshuang Xie; Liwei Cui; Chunyan Zheng; Wei Xiao
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-11-20

8.  PGAM5 expression and macrophage signatures in non-small cell lung cancer associated with chronic obstructive pulmonary disease (COPD).

Authors:  F Ng Kee Kwong; A G Nicholson; S Pavlidis; I M Adcock; K F Chung
Journal:  BMC Cancer       Date:  2018-12-10       Impact factor: 4.430

9.  Prognostic significance of CT-determined emphysema in patients with small cell lung cancer.

Authors:  Hee Young Lee; Eun Young Kim; Young Saing Kim; Hee Kyung Ahn; Yoon Kyung Kim
Journal:  J Thorac Dis       Date:  2018-02       Impact factor: 2.895

10.  Clinical and radiological characteristics of central pulmonary adenocarcinoma: a comparison with central squamous cell carcinoma and small cell lung cancer and the impact on treatment response.

Authors:  Zhe Wang; Minghuan Li; Yong Huang; Li Ma; Hui Zhu; Li Kong; Jinming Yu
Journal:  Onco Targets Ther       Date:  2018-05-04       Impact factor: 4.147

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.